Frank Wooten is the founder of Arkea Bio. Arkea Bio has raised $40M in total funding. Latest round: Series A. Based in Boston, United States.
Frank Wooten is the CEO of ArkeaBio, a Boston-based agricultural bioscience company focused on developing a vaccine to reduce methane emissions from cattle. He joined ArkeaBio in September 2025, after co-founding Vence, a virtual fencing company. He is responsible for commercializing ArkeaBio's methane-reducing vaccine technology.
Full founder directory · Investor directory · Company funding database · Fundraising library